Search research articles
Contact Us
Filters
Showing results (51-60 of 117) with videos related to
Page
of 12
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 19, 2025
Development of Simplified Risk Assessment Scoring System for Sarcopenia in Patients With Chronic Liver Disease
Atsushi Hiraoka, Hideko Ohama, Fujimasa Tada, et al.
Cancer Medicine
|
December 17, 2025
Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification
Fujimasa Tada, Atsushi Hiraoka, Hideko Ohama, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
May 22, 2025
History of Previous Medication Self-Discontinuation Predicts the Current Adherence to 5-Aminosalicylates in Patients With Ulcerative Colitis
Shogo Kitahata, Ayaka Nakamura, Yuka Kimura, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 21, 2025
Characteristics of Adult Intussusception due to Malignancy in Japanese Patients
Shogo Kitahata, Ayaka Nakamura, Yuka Kimura, et al.
Clinical Journal of Gastroenterology
|
March 26, 2024
Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy
Fujimasa Tada, Atsushi Hiraoka, Kosuke Nakatani, et al.
Hepatology International
|
June 12, 2026
Identifying a biologically high-risk subgroup of anatomically resectable hepatocellular carcinoma
Kazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 11, 2025
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 21, 2026
The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
Van Khanh Nguyen, Kosuke Matsui, Hisashi Kosaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 22, 2025
Dynamic changes in the characteristics of hepatocellular carcinoma among Japanese patients: Increasing incidence of cases without liver fibrosis
Fujimasa Tada, Atsushi Hiraoka, Hideko Ohama, et al.
Journal of Medical Virology
|
March 6, 2026
Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus Infection
Hidenori Toyoda, Akito Nozaki, Atsushi Hiraoka, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 117) with videos related to
Sort By:
Page
of 12
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 19, 2025
Development of Simplified Risk Assessment Scoring System for Sarcopenia in Patients With Chronic Liver Disease
Atsushi Hiraoka, Hideko Ohama, Fujimasa Tada, et al.
Cancer Medicine
|
December 17, 2025
Prognostic Stratification of Initial Treatments for Hepatocellular Carcinoma Using a Modified Borderline Resectable Classification
Fujimasa Tada, Atsushi Hiraoka, Hideko Ohama, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
May 22, 2025
History of Previous Medication Self-Discontinuation Predicts the Current Adherence to 5-Aminosalicylates in Patients With Ulcerative Colitis
Shogo Kitahata, Ayaka Nakamura, Yuka Kimura, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
February 21, 2025
Characteristics of Adult Intussusception due to Malignancy in Japanese Patients
Shogo Kitahata, Ayaka Nakamura, Yuka Kimura, et al.
Clinical Journal of Gastroenterology
|
March 26, 2024
Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy
Fujimasa Tada, Atsushi Hiraoka, Kosuke Nakatani, et al.
Hepatology International
|
June 12, 2026
Identifying a biologically high-risk subgroup of anatomically resectable hepatocellular carcinoma
Kazunari Tanaka, Kunihiko Tsuji, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 11, 2025
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
March 21, 2026
The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
Van Khanh Nguyen, Kosuke Matsui, Hisashi Kosaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
May 22, 2025
Dynamic changes in the characteristics of hepatocellular carcinoma among Japanese patients: Increasing incidence of cases without liver fibrosis
Fujimasa Tada, Atsushi Hiraoka, Hideko Ohama, et al.
Journal of Medical Virology
|
March 6, 2026
Changes in the Liver Fibrosis of Patients Who Develop Hepatocellular Carcinoma After a Sustained Virologic Response to Hepatitis C Virus Infection
Hidenori Toyoda, Akito Nozaki, Atsushi Hiraoka, et al.
Page
of 12